Genetic variants and social benefit receipt in premenopausal women with breast cancer treated with docetaxel: a Danish population-based cohort study.

Julie A Schmidt Cathrine Fonnesbech Hjorth Dóra Körmendiné Farkas Per Damkier Søren Feddersen Stephen Jacques Hamilton-Dutoit Bent Ejlertsen Timothy L Lash Thomas Patrick Ahern Deirdre P Cronin-Fenton

Published in: Breast cancer research and treatment (2024)

We found no clinically meaningful impact of the selected SNPs on social benefit receipt among premenopausal breast cancer survivors treated with docetaxel.

Keyphrases

postmenopausal women
healthcare
mental health
genome wide
newly diagnosed
squamous cell carcinoma
breast cancer risk
gene expression
radiation therapy